Clinical Trial Update: Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for a combination therapy of natamycin and voriconazole in fungal keratitis, spanning Phase 2 and Phase 3, with status currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Keratitis

Drugs mentioned

• Natamycin (natamycin)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: L.V. Prasad Eye Institute | Conditions: Infection, Fungal | Phase 2, Phase 3 | Status: UNKNOWN